JGC
AVDL

J. Goldman & Co’s Avadel Pharmaceuticals AVDL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.33M Buy
263,363
+47,363
+22% +$419K 0.06% 193
2025
Q1
$1.69M Buy
216,000
+175,653
+435% +$1.38M 0.04% 208
2024
Q4
$424K Sell
40,347
-48,033
-54% -$505K 0.01% 269
2024
Q3
$1.16M Sell
88,380
-86,572
-49% -$1.14M 0.03% 189
2024
Q2
$2.46M Buy
+174,952
New +$2.46M 0.07% 159
2024
Q1
Hold
0
282
2023
Q4
Sell
-163,382
Closed -$1.68M 219
2023
Q3
$1.68M Buy
163,382
+134,609
+468% +$1.39M 0.06% 142
2023
Q2
$474K Sell
28,773
-152,227
-84% -$2.51M 0.02% 191
2023
Q1
$1.66M Buy
181,000
+106,750
+144% +$978K 0.07% 153
2022
Q4
$532K Buy
+74,250
New +$532K 0.03% 202
2021
Q1
Sell
-233,747
Closed -$1.56M 326
2020
Q4
$1.56M Sell
233,747
-174,878
-43% -$1.17M 0.08% 168
2020
Q3
$2.06M Sell
408,625
-239,083
-37% -$1.2M 0.14% 123
2020
Q2
$5.23M Buy
+647,708
New +$5.23M 0.32% 63
2018
Q1
Sell
-77,000
Closed -$631K 240
2017
Q4
$631K Sell
77,000
-314,839
-80% -$2.58M 0.03% 157
2017
Q3
$4.11M Sell
391,839
-274,477
-41% -$2.88M 0.21% 75
2017
Q2
$7.35M Sell
666,316
-330,684
-33% -$3.65M 0.4% 44
2017
Q1
$9.65M Buy
+997,000
New +$9.65M 0.48% 29
2016
Q4
Sell
-823,000
Closed -$10.2M 202
2016
Q3
$10.2M Sell
823,000
-474,415
-37% -$5.88M 0.58% 26
2016
Q2
$13.9M Buy
1,297,415
+179,415
+16% +$1.93M 0.73% 16
2016
Q1
$12.3M Buy
1,118,000
+495,000
+79% +$5.46M 0.77% 23
2015
Q4
$7.61M Buy
623,000
+210,120
+51% +$2.57M 0.78% 19
2015
Q3
$6.73M Buy
412,880
+384,465
+1,353% +$6.27M 0.58% 34
2015
Q2
$602K Buy
28,415
+3,415
+14% +$72.4K 0.04% 130
2015
Q1
$450K Sell
25,000
-78,125
-76% -$1.41M 0.03% 156
2014
Q4
$1.77M Buy
+103,125
New +$1.77M 0.21% 83